Dow Up0.25% Nasdaq Up0.65%

More On CMXHF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

CSL Ltd. (CMXHF)

-Other OTC
82.50 0.00(0.00%) N/A
ProfileGet Profile for:
CSL Ltd.
45 Poplar Road
Parkville, VIC 3052
Australia - Map
Phone: 61 3 9389 1911
Fax: 61 3 9389 1434
Website: http://www.csl.com.au

Details 
Index Membership:N/A
Sector:N/A
Industry:N/A
Full Time Employees:N/A

Business Summary 

CSL Ltd. engages in the research, development, manufacture, marketing, and distribution of biopharmaceutical and allied products in Australia, the United States, Germany, Switzerland, and internationally. The company operates through CSL Behring, bioCSL, and CSL Intellectual Property segments. The CSL Behring segment develops, manufactures, and markets plasma products and recombinants, which are used to treat coagulation disorders, including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease, and neurological disorders. Its products are also used in cardiac surgery, organ transplantation, and burn treatment, as well as to prevent hemolytic diseases in the newborns. The bioCSL segment manufactures and markets biological products for human use; in-licenses and markets vaccines and prescription pharmaceuticals to treat a range of human medical conditions; and manufactures and markets in vitro diagnostic products. The CSL Intellectual Property segment licenses intellectual property to unrelated third parties. The company also markets a range of vaccines and antivenoms, as well as pharmaceutical products supplied by other manufacturers. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on CSL Ltd.

Key Executives 
 PayExercised
Mr. Paul R. Perreault BA Psychology, 59
Chief Exec. Officer, Managing Director, Exec. Director, Member of Innovation & Devel. Committee and Member of Securities & Market Disclosure Committee
N/AN/A
Dr. Andrew Cuthbertson BMedSci, MBBS, Ph.D., FTSE, FAHMS, 61
Chief Scientific officer and Director of R&D
N/AN/A
Mr. Gregory Boss J.D., BS(Hon), 55
Exec. VP of Legal, Group Gen. Counsel, Exec. VP of CSL Behring and Gen. Counsel of CSL Behring
N/AN/A
Ms. Laurie Reed BS (Finance), MS (Organizational Development), 52
Sr. VP of HR
N/AN/A
Dr. Karen Etchberger Ph.D., 58
Exec. VP of Quality & Bus. Services
N/AN/A
Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.